Giving the Thomas Starzl transplant state of the art lecture this year is Peter Friend, on normothermic transplantation — the ice box is now the rate limiting step, especially for extended criteria organs #TLM22@OxTxResearch
Published trials for benefits of normothermic perfusion devices accumulating, typically reduced acute liver injury, post-reperfusion syndrome, utilisation, and preservation time - but randomisation process in this setting introduces inherent selection biases #TLM22
Upcoming PLUS trial uses a prospective NMP arm and identical criteria retrospective control arm, given investigators unwilling to randomise higher risk of organs #TLM22
A new schema for centrally managing, assessing and repairing grafts, eg through removal of fat (and RCT on perfusion+lipid filter+pharmacological imminent in UK…) is being actively considered in the UK, SPAIN, and the US #TLM22
• • •
Missing some Tweet in this thread? You can try to
force a refresh
280 HBeAg+ mothers gestational age 12-13 weeks randomised 1:1 to early TDF from GW 14, or control group of TDF at GW 28. All infants got active immunoprophylaxis and HBIg only given to infants in the control group; 1ry endpoint HBV transmission at 28 weeks #TLM22
Women in experimental arm had lower HBV DNA at delivery; there was no transmission of HBV to infants in either group. A sensitivity analysis suggested a conservative 2% infection rate in experimental arm. Safety similar, but small numbers #TLM22